Search - tctmd.com

Displaying 141 - 160 of 2221

Sort: Relevancy | Date

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 31, 2016

Presentation TCT 2016

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Jonathan M. Hill

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello

October 31, 2016

Presentation TCT 2016

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Daniel Burkhoff

October 31, 2016

Presentation TCT 2016

TCT 42: Transcatheter Echo Guided Mitral Valve Repair With Neochord Implantation for Posterior Leaflet Disease: Results From Neochord Independent International Registry

Presenter: Stephan Baldus, Allan Schwartz, Andrea Colli

October 31, 2016

Presentation TCT 2016

Rationale for and Design of GALILEO

Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja

October 31, 2016

News Industry News

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

News Industry News

Study Indicates That Open Heart Surgery May Be Superior To PCI For Treatment Of Left Main Coronary Artery Disease

October 31, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Presenter: Michael J. Lim, Payam Dehghani

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Presenter: Michael J. Lim, Molly Szerlip

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR

Presenter: Dmitriy N. Feldman, Rahul Sakhuja

October 31, 2016

Presentation TCT 2016

Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closure of the Left Atrial Appendage in a Elderly Comorbid Patient

Presenter: Maurice Buchbinder, Horst Sievert, Caterina Gandolfo

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Real-time 3D Guidance in Recanalization of Interrupted Aorta

Presenter: Maurice Buchbinder, Horst Sievert, C. Huie Lin

October 31, 2016

Presentation TCT 2016

Severe Bicuspid Aortic Valve Disease

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, Vinayak Bapat

October 31, 2016

Advertisement

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 42: Transcatheter Echo Guided Mitral Valve Repair With Neochord Implantation for Posterior Leaflet Disease: Results From Neochord Independent International Registry

Rationale for and Design of GALILEO

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Study Indicates That Open Heart Surgery May Be Superior To PCI For Treatment Of Left Main Coronary Artery Disease

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR

Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closure of the Left Atrial Appendage in a Elderly Comorbid Patient

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Real-time 3D Guidance in Recanalization of Interrupted Aorta

Severe Bicuspid Aortic Valve Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content